These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23335473)

  • 21. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychosis prevention: expectations met].
    Bechdolf A; Peukert R
    Psychiatr Prax; 2011 Feb; 38(2):58-60. PubMed ID: 21394689
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
    McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
    JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specialised early intervention teams for recent-onset psychosis.
    Puntis S; Minichino A; De Crescenzo F; Cipriani A; Lennox B; Harrison R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013288. PubMed ID: 33135811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.
    Bighelli I; Rodolico A; García-Mieres H; Pitschel-Walz G; Hansen WP; Schneider-Thoma J; Siafis S; Wu H; Wang D; Salanti G; Furukawa TA; Barbui C; Leucht S
    Lancet Psychiatry; 2021 Nov; 8(11):969-980. PubMed ID: 34653393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Brooke-Powney MJ; Li X; Adams CE
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009377. PubMed ID: 28758203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
    Mees L; Zdanowicz N; Reynaert C; Jacques D
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for a systematic review and meta-analysis of cognitive-behavioural therapy for social anxiety disorder in psychosis.
    Michail M; Birchwood M; Tait L
    Syst Rev; 2014 Jun; 3():62. PubMed ID: 24920188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
    Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis.
    Ostinelli EG; D'Agostino A; Shokraneh F; Salanti G; Furukawa TA
    BMJ Open; 2019 Oct; 9(10):e032726. PubMed ID: 31601607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.
    van der Gaag M; Smit F; Bechdolf A; French P; Linszen DH; Yung AR; McGorry P; Cuijpers P
    Schizophr Res; 2013 Sep; 149(1-3):56-62. PubMed ID: 23870806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive Behavioral Therapy for Prodromal Stage of Psychosis-Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis.
    Zheng Y; Xu T; Zhu Y; Li C; Wang J; Livingstone S; Zhang T
    Schizophr Bull; 2022 Jan; 48(1):8-19. PubMed ID: 33944949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis.
    Mei C; van der Gaag M; Nelson B; Smit F; Yuen HP; Berger M; Krcmar M; French P; Amminger GP; Bechdolf A; Cuijpers P; Yung AR; McGorry PD
    Clin Psychol Rev; 2021 Jun; 86():102005. PubMed ID: 33810885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.